Article
Alzheimer’s Disease cerebrospinal fluid Biomarkers and kidney function in normal and cognitively impaired older adults
2023-11-01
Abstract excerpt
<h4>Importance</h4> Recent Alzheimer’s disease (AD) clinical trials have used Cerebrospinal fluid (CSF) biomarker levels for screening and enrollment. Preliminary evidence suggests Alzheimer’s Disease (AD) risk may be related to impaired renal function but the association of variation in levels of commonly used AD biomarkers with kidney function are unknown. <h4>Objective</h4> To investigate the association betwee...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 40c1647a-5ad4-5c06-8f12-7c4adbd16f7f
- DOI
- 10.1101/2023.11.01.23297910
